Mark L Berch

Array ( [id] => 8549317 [patent_doc_number] => 08324198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-12-04 [patent_title] => 'Monocarbams' [patent_app_type] => utility [patent_app_number] => 13/558989 [patent_app_country] => US [patent_app_date] => 2012-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21252 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13558989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8484032 [patent_doc_number] => 20120283438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/551946 [patent_app_country] => US [patent_app_date] => 2012-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 90257 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13551946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675696 [patent_doc_number] => 08383810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Process for the synthesis of azetidinones' [patent_app_type] => utility [patent_app_number] => 13/323366 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11452 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371377 [patent_doc_number] => 20120220765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'BETA-LACTAMYL PHENYLALANINE, CYSTEINE, AND SERINE VASOPRESSIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/285590 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25634 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13285590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778507 [patent_doc_number] => 20120040982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/280396 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54114 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040982.pdf [firstpage_image] =>[orig_patent_app_number] => 13280396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7767965 [patent_doc_number] => 20120035158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 13/280394 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72285 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035158.pdf [firstpage_image] =>[orig_patent_app_number] => 13280394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199384 [patent_doc_number] => 20120122840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'COMPOUNDS AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/243876 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 63436 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122840.pdf [firstpage_image] =>[orig_patent_app_number] => 13243876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711912 [patent_doc_number] => 20120004212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/218865 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58553 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13218865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768048 [patent_doc_number] => 20120035192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/190136 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13951 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035192.pdf [firstpage_image] =>[orig_patent_app_number] => 13190136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555423 [patent_doc_number] => 08329895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Cefdinir acid double salt and method for producing the same' [patent_app_type] => utility [patent_app_number] => 13/172907 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8604 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549342 [patent_doc_number] => 08324224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/169834 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31570 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574125 [patent_doc_number] => 20110269781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/154818 [patent_app_country] => US [patent_app_date] => 2011-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 90230 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269781.pdf [firstpage_image] =>[orig_patent_app_number] => 13154818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487329 [patent_doc_number] => 20110236348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'MODULATORS OF TOLL-LIKE RECEPTOR 7' [patent_app_type] => utility [patent_app_number] => 13/153340 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36357 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236348.pdf [firstpage_image] =>[orig_patent_app_number] => 13153340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696110 [patent_doc_number] => 20110230480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => '8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/118166 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27675 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230480.pdf [firstpage_image] =>[orig_patent_app_number] => 13118166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675521 [patent_doc_number] => 08383634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Methods of treatment using heteroaryl compounds and compositions thereof' [patent_app_type] => utility [patent_app_number] => 13/113135 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91520 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13113135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511495 [patent_doc_number] => 20110257205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/088962 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 56853 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257205.pdf [firstpage_image] =>[orig_patent_app_number] => 13088962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797101 [patent_doc_number] => 08435969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Method and compositions for treating hematological malignancies' [patent_app_type] => utility [patent_app_number] => 13/070179 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4958 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13070179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017184 [patent_doc_number] => 20110224425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'PROCESS FOR PRODUCING CARBAPENEM DERIVATIVE AND INTERMEDIATE CRYSTAL THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/052363 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6634 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224425.pdf [firstpage_image] =>[orig_patent_app_number] => 13052363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016676 [patent_doc_number] => 20110224186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'CARBACEPHEM BETA-LACTAM ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 13/044800 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28083 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224186.pdf [firstpage_image] =>[orig_patent_app_number] => 13044800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083946 [patent_doc_number] => 20110144095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/032685 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54073 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144095.pdf [firstpage_image] =>[orig_patent_app_number] => 13032685 [rel_patent_id] =>[rel_patent_doc_number] =>)